MONDAY, March 11, 2024 (HealthDay News) — Following disappointing trial results, the maker of a controversial ALS drug may pull the medication off the market. In a statement issued Friday, Amylyx Pharmaceuticals said that Relyvrio failed to help patients in a large follow-up study, but the company stopped just shortContinue Reading
MONDAY, March 11, 2024 (HealthDay News) — Kids struggling with mental health problems have a tougher time recovering from a concussion, a new study finds. These troubled kids tend to have more emotional symptoms after concussion and take longer to fully recover, results show. In fact, the more mental healthContinue Reading
MONDAY, March 11, 2024 (HealthDay News) — New technology might soon allow men in same-sex relationships to have a child genetically related to both dads, researchers say. The technology uses skin cells from one person to alter the genetics of a donated egg, researchers reported March 8 in the journalContinue Reading
MONDAY, March 11, 2024 (HealthDay News) — Days clogged with numerous after-school activities are detrimental to the mental health of over-scheduled high school students, a new study finds. Researchers also found that these “enrichment’ activities — tutoring, sports, school clubs and even homework — are unlikely to benefit students academically.Continue Reading
FRIDAY, March 8, 2024 (HealthDay News) — Real-world data show that a shot that protects babies against RSV is 90% effective in keeping them out of the hospital. Those numbers outstrip what had been expected of Beyfortus (nirsevimab), which in clinical trials had prevented the need for medical care forContinue Reading
MONDAY, March 11, 2024 (HealthDay News) — The COVID-19 virus can linger in the blood and tissue of patients for more than a year after they’ve shaken their initial infection, new findings show. Researchers found pieces of SARS-CoV-2, the virus behind COVID, lingering in the blood for up to 14Continue Reading
MONDAY, March 11, 2024 (HealthDay News) — A cancer drug duo more than doubled the survival of people battling the most common form of advanced bladder cancer, trial results show. Patients who took a combo of meds called EV+P — enfortumab vedotin and pembrolizumab (Keytruda) — had an average 31.5Continue Reading
SATURDAY, March 9, 2024 (HealthDay News) — Endometriosis causes crippling pain in women, with some spending up to a month of every year debilitated by it. “We’re talking about pain that’s beyond ‘I took two ibuprofen and went to work,’” said Dr. Kristin Riley, chief of minimally invasive gynecologic surgeryContinue Reading
FRIDAY, March 8, 2024 (HealthDay News) — Wegovy (semaglutide), the weight-loss version of blockbuster diabetes drug Ozempic, was approved on Friday by the U.S. Food and Drug Administration to help prevent heart attack, stroke and heart death. “Wegovy is now the first weight-loss medication to also be approved to helpContinue Reading
FRIDAY, March 8, 2024 (HealthDay News) — When the clocks spring forward or fall back, many folks will find themselves struggling to adjust. The transition to Daylight Saving Time each Spring is the toughest on people, both mentally and physically. Research has found that people “springing forward” have an increasedContinue Reading